@article{5493b8890b7c4dac826c39ab586d4ecb,
title = "Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry",
abstract = "Here we present an optimized workflow for global proteome and phosphoproteome analysis of tissues or cell lines that uses isobaric tags (TMT (tandem mass tags)-10) for multiplexed analysis and relative quantification, and provides 3× higher throughput than iTRAQ (isobaric tags for absolute and relative quantification)-4-based methods with high intra-and inter-laboratory reproducibility. The workflow was systematically characterized and benchmarked across three independent laboratories using two distinct breast cancer subtypes from patient-derived xenograft models to enable assessment of proteome and phosphoproteome depth and quantitative reproducibility. Each plex consisted of ten samples, each being 300 μg of peptide derived from <50 mg of wet-weight tissue. Of the 10,000 proteins quantified per sample, we could distinguish 7,700 human proteins derived from tumor cells and 3100 mouse proteins derived from the surrounding stroma and blood. The maximum deviation across replicates and laboratories was <7%, and the inter-laboratory correlation for TMT ratio-based comparison of the two breast cancer subtypes was r > 0.88. The maximum deviation for the phosphoproteome coverage was <24% across laboratories, with an average of >37,000 quantified phosphosites per sample and differential quantification correlations of r > 0.72. The full procedure, including sample processing and data generation, can be completed within 10 d for ten tissue samples, and 100 samples can be analyzed in ∼4 months using a single LC-MS/MS instrument. The high quality, depth, and reproducibility of the data obtained both within and across laboratories should enable new biological insights to be obtained from mass spectrometry-based proteomics analyses of cells and tissues together with proteogenomic data integration.",
author = "Philipp Mertins and Tang, {Lauren C.} and Karsten Krug and Clark, {David J.} and Gritsenko, {Marina A.} and Lijun Chen and Clauser, {Karl R.} and Clauss, {Therese R.} and Punit Shah and Gillette, {Michael A.} and Petyuk, {Vladislav A.} and Thomas, {Stefani N.} and Mani, {D. R.} and Filip Mundt and Moore, {Ronald J.} and Yingwei Hu and Rui Zhao and Michael Schnaubelt and Hasmik Keshishian and Monroe, {Matthew E.} and Zhen Zhang and Udeshi, {Namrata D.} and Davies, {Sherri R.} and Townsend, {R. Reid} and Chan, {Daniel W.} and Smith, {Richard D.} and Hui Zhang and Tao Liu and Carr, {Steven A.}",
note = "Funding Information: We thank M.J. Ellis of the Lester and Sue Smith Breast Center, the Dan L. Duncan Comprehensive Cancer Center and the Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, and S. Li of the Human and Mouse Linked Evaluation of Tumor Core, Division of Oncology, Washington University School of Medicine, for development of the breast xenograft samples used; and J. Snider and P. Erdmann-Gilmore for the large-scale preparation of the cryopulverized tumor tissue. We also thank S. Stein and S. Markey of the National Institutes of Science and Technology for insightful comments. This work was supported by grants from the National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium ((CPTAC) to S.A.C. and M.A.G. at the Broad Institute of MIT and Harvard (1U24CA210986); to T.L. and R.D.S. at the Pacific Northwest National Laboratories (U24CA210955); to D.W.C., H.Z. and Z.Z. at Johns Hopkins University (U24CA210985); and to R.R.T. (U24CA160035). Proteomics work at PNNL described herein was carried out in the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy (DOE) national scientific user facility located at PNNL in Richland, Washington. PNNL is a multiprogram national laboratory operated by the Battelle Memorial Institute for the DOE under contract DE-AC05-76RL01830. Research reported in this publication was supported by a Washington University Institute of Clinical and Translational Sciences grant (UL1 TR000448) from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. Publisher Copyright: {\textcopyright} 2018 The Author(s).",
year = "2018",
month = jul,
day = "1",
doi = "10.1038/s41596-018-0006-9",
language = "English (US)",
volume = "13",
pages = "1632--1661",
journal = "Nature protocols",
issn = "1754-2189",
publisher = "Nature Publishing Group",
number = "7",
}